Memorial Sloan Kettering Cancer Center

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1884-01-01

Employees: 10K

Market Cap: -

Website: http://www.mskcc.org

Clinical Trials

Verbal and Written Instruction Versus Verbal and Written Plus Simulation in Patients With Breast Cancer and Their Caregivers

Completed

Conditions: Breast Cancer

Interventions: Other: Verbal and Written Instruction
Other: Verbal and Written Plus Simulation

First Posted Date: 2013-04-11

Last Posted Date: 2015-09-04

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 51

Registration Number: NCT01829984

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Comprehensive Geriatric Assessment to Predict Toxic Events in Older Patients With Non-Hodgkin Lymphoma With Imbedded Pilot Study of Pre-Phase Therapy

Not Applicable

Active, not recruiting

Conditions: Diffuse Large B-cell Lymphoma (DLBCL)
Non Hodgkin Lymphoma (NHL)

Interventions: Drug: rituximab
Drug: prednisone
Behavioral: Geriatric Assessment

First Posted Date: 2013-04-11

Last Posted Date: 2024-05-06

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 201

Registration Number: NCT01829958

Locations: 🇺🇸
Memorial Sloan Kettering Monmouth, Middletown, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Bergen, Montvale, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Basking Ridge, Basking Ridge, New Jersey, United States

and more 5 locations

First Line Gemcitabine, Cisplatin and MEK162 in Advanced Biliary Tract Carcinoma

Phase 1

Completed

Conditions: Advanced Biliary Tract Carcinoma

Interventions: Drug: Gemcitabine
Drug: Cisplatin
Drug: MEK162

First Posted Date: 2013-04-10

Last Posted Date: 2020-11-17

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 42

Registration Number: NCT01828034

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Paclitaxel With Trastuzumab and Lapatinib in HER2-Positive Early Stage Breast Cancer

Phase 2

Completed

Conditions: HER2-Positive Early Stage Breast Cancer

Interventions: Drug: Paclitaxel
Drug: Trastuzumab
Drug: Lapatinib
Drug: Pegfilgrastim

First Posted Date: 2013-04-09

Last Posted Date: 2019-12-18

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 20

Registration Number: NCT01827163

Locations: 🇺🇸
Memorial Sloan Kettering Basking Ridge, Basking Ridge, New Jersey, United States
🇺🇸
Memorial Sloan-Kettering Cancer Commack, Commack, New York, United States
🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

and more 1 locations

Intraoperative Detection of Lesions Using PET (Positron Emission Tomography) Probe During Secondary Cytoreductive Surgery for Recurrent Ovarian, Fallopian Tube and Primary Peritoneal Cancer

Not Applicable

Completed

Conditions: Primary Peritoneal
Ovarian Cancer
Fallopian Tube

Interventions: Procedure: Positron Emission Tomography
Radiation: 18F-Fluoro-2-deoxy-D-lucose
Procedure: Cytoreductive surgery

First Posted Date: 2013-04-08

Last Posted Date: 2017-11-06

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 5

Registration Number: NCT01826227

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

ICARuS Post-operative Intraperitoneal Chemotherapy (EPIC) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) After Optimal Cytoreductive Surgery (CRS) for Neoplasms of the Appendix, Colon or Rectum With Isolated Peritoneal Metastasis

Phase 2

Active, not recruiting

Conditions: Appendix Cancer
Colorectal Cancer

Interventions: Procedure: Cytoreductive Surgery
Drug: HIPEC with Mitomycin-C
Drug: EPIC with FUDR and Leucovorin

First Posted Date: 2013-03-21

Last Posted Date: 2024-02-02

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 292

Registration Number: NCT01815359

Locations: 🇺🇸
University of Miami, Miami, Florida, United States
🇺🇸
Memorial Sloan Kettering Bergen (Consent and Follow up), Montvale, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Westchester (Consent and Follow up), Harrison, New York, United States

and more 6 locations

A Registry for Patients Treated on the Clinical Trial TAX 3503

Completed

Conditions: Prostate Cancer

Interventions: Other: No intervention

First Posted Date: 2013-03-19

Last Posted Date: 2022-03-08

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 52

Registration Number: NCT01813370

Locations: 🇱🇹
Klaipeda University Hospital, Klaipeda, Lithuania
🇺🇸
John Hopkins Medical Center, Baltimore, Maryland, United States
🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

and more 5 locations

Acupuncture for Symptom Control in Hematopoietic Stem Cell Transplantation Patients

Not Applicable

Completed

Conditions: Multiple Myeloma

Interventions: Procedure: Acupuncture
Procedure: Sham acupuncture

First Posted Date: 2013-03-15

Last Posted Date: 2021-12-14

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 63

Registration Number: NCT01811862

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Training Model to Advance Support of the Family as a Caregiving System in the Inpatient Oncology Setting

Not Applicable

Active, not recruiting

Conditions: Support of the Family as a Caregiving System

Interventions: Behavioral: Working with the Caregiving Family (WCF) training
Behavioral: questionnaires

First Posted Date: 2013-03-06

Last Posted Date: 2024-03-04

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 80

Registration Number: NCT01805609

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Community Primary Care Providers to Implement and Disseminate Cancer Prevention Interventions for Latino Populations

Terminated

Conditions: For New York State Registered Family Practitioners and Internal Medicine Physicians

Interventions: Behavioral: in-depth, semi-structured interviews

First Posted Date: 2013-03-04

Last Posted Date: 2015-02-20

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 3

Registration Number: NCT01803750

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy